首页> 美国卫生研究院文献>Diabetes Metabolic Syndrome and Obesity: Targets and Therapy >Research Progress on Gestational Diabetes Mellitus and Endothelial Dysfunction Markers
【2h】

Research Progress on Gestational Diabetes Mellitus and Endothelial Dysfunction Markers

机译:妊娠期糖尿病和内皮功能障碍标记的研究进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Gestational diabetes mellitus (GDM) is the onset or first recognition of diabetes during pregnancy in women with normal glucose metabolism or potentially impaired glucose tolerance before pregnancy. Studies have shown that vascular endothelial cells (VECs) are an important target organ of insulin, which is injured by multiple factors in the case of GDM, thereby leading to worsened insulin resistance (IR) and the further development of GDM. When VECs are abnormal, there will be changes in the content of a variety of cell markers, which may be helpful for the clinical prediction and diagnosis of GDM. This study attempted to investigate the mechanism and markers of VECs injury in GDM patients.
机译:妊娠期糖尿病Mellitus(GDM)是在妊娠正常葡萄糖代谢的女性妊娠期间的糖尿病的发病或首先识别,或者在怀孕前潜在受损的葡萄糖耐量。研究表明,血管内皮细胞(VECS)是胰岛素的重要靶器官,其在GDM的情况下受到多种因素的损伤,从而导致胰岛素抵抗(IR)恶化和GDM的进一步发展。当VECS异常时,各种细胞标记物的含量会发生变化,这可能有助于GDM的临床预测和诊断。本研究试图探讨GDM患者VECS损伤的机制和标志。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号